Outcomes of drug-eluting stents compared to bare-metal stents in ST-segment elevation acute myocardial infarction
Introduction: Primary percutaneous coronary intervention (PPCI) has become the treatment of choice in patients with ST-segment elevation myocardial infarction (STEMI). Drug-eluting stents (DES) reduce restenosis compared to bare-metal stents (BMS) but there is conflicting data concerning their use i...
Main Authors: | João Brito, Manuel Almeida, Rui Campante Teles, Pedro Sousa, João Abecasis, Rita Calé, Pedro Gonçalves, Luís Raposo, Miguel Mendes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-11-01
|
Series: | Revista Portuguesa de Cardiologia (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2174204911000213 |
Similar Items
-
Outcomes of drug-eluting stents compared to bare-metal stents in ST-segment elevation acute myocardial infarction
by: João Brito, et al.
Published: (2011-11-01) -
Comparison of Drug-Eluting Stents and Bare-Metal Stents in Reinfarction on ST-Elevation Myocardial Infarction Patients
by: Oryza G. Prabu, et al.
Published: (2014-12-01) -
Long-term Outcomes of Drug-eluting versus Bare-metal stent for ST-elevation Myocardial Infarction
by: Liping Wang, et al.
Published: (2014-06-01) -
Ten-year survival of patients undergoing coronary angioplasty with first-generation sirolimus-eluting stents and bare-metal stents
by: Nelson Vale, et al.
Published: (2020-11-01) -
Ten-year survival of patients undergoing coronary angioplasty with first-generation sirolimus-eluting stents and bare-metal stents
by: Nelson Vale, et al.
Published: (2020-11-01)